Cite
HARVARD Citation
Baalbaki, N. et al. (n.d.). 1259. Carbapenems Versus Non-carbapenem Beta-Lactams for the Treatment of Ceftriaxone-Susceptible and Piperacillin-Tazobactam-Nonsusceptible Enterobacterales Isolates. Open forum infectious diseases. p. S718. [Online].